Lit Matters #1: CCTA for NSTEMI?

Coronary CT angiography may risk-stratify NSTEMI and NSTE-ACS nearly as well as invasive coronary angiography. The key clinical question is whether CCTA can act as a gatekeeper to the cath lab without missing prognostically important coronary disease.

CCTA for NSTEMI Risk Stratification

• Comparable prognostic signal: In NSTE-ACS, coronary CTA tracked long-term outcomes at least as well as invasive angiography when patients were grouped by CAD severity and extent.
• Obstructive CAD matters: Patients with obstructive disease had roughly a 1.5- to 1.7-fold higher rate of death, recurrent MI, refractory ischemia, or heart failure than those with nonobstructive CAD.
• High-risk anatomy detection: CTA identified patients with high-risk obstructive CAD who carried worse long-term outcomes, and it flagged more high-risk anatomy than invasive angiography.
• Gatekeeper cath-lab concept: A normal or nonobstructive CTA raises the possibility that some NSTEMI patients may not benefit from routine invasive angiography, a distinction we get into in the episode.
• Anatomic versus functional testing: CCTA is primarily an anatomic test, while invasive angiography can extend to functional and plaque-level assessment with tools like IVUS and OCT.
• Major unanswered limitation: The study reports hazard ratios rather than false-positive and false-negative performance, so it is less helpful for deciding what a single patient's CTA result truly means.